Home
Company
Product
Regulation
China
Data
Exhibition
Interview
中文版
Home
Company
Product
Regulation
China
Data
Exhibition
Interview
中文版
Search

PMI Launches IQOS ILUMA i Series in Saudi Arabia to Support a Smoke-Free Future

Jul.09
PMI Launches IQOS ILUMA i Series in Saudi Arabia to Support a Smoke-Free Future
Philip Morris International (PMI) has launched its next-generation heated tobacco products, the IQOS ILUMA i series, in Saudi Arabia, debuting with two devices: ILUMA i PRIME and ILUMA i.

Key Points:

 

·Saudi Arabia has become the latest market for IQOS ILUMA i, the newest smoke-free product introduced by Philip Morris International (PMI). 

 

·IQOS ILUMA i reduces 95% of harmful chemicals through innovative technology. 

 

·PMI is working towards a smoke-free future, supporting Saudi Arabia's sustainable development goals. 

 

·As of the first quarter of 2025, PMI generates more than 40% of its revenue from smoke-free products. 

 

【2Firsts News Flash】According to Arab News on July 8th, Philip Morris International (PMI) has officially launched its latest heated tobacco product, the IQOS ILUMA i series, in Saudi Arabia, which includes three devices: ILUMA i PRIME, ILUMA i, and ILUMA i ONE.

 

IQOS ILUMA i series products all adopt PMI's exclusive SMARTCORE induction heating technology, providing a cleaner and smoother user experience. Currently, the ILUMA i PRIME and ILUMA i devices have been launched in the Saudi market.

 

Chrisitian Akiki, the General Manager of Philip Morris International's Saudi branch, emphasized that this initiative is aimed at reducing the harm caused by tobacco and aligns with Saudi Arabia's Vision 2030 and its sustainable development goals. He highlighted that the launch of IQOS ILUMA i signifies a key advancement towards a smoke-free future and stated that the product is a result of years of scientific research and market experience, achieving significant technological breakthroughs.

 

Archy believes that through technological innovation, regulatory support, and community collaboration, the global decline in traditional cigarette use can be accelerated.

 

Ogi Kapitanovic, the head of smoke-free products, added that IQOS ILUMA i is currently the most innovative smoke-free product, with harmful chemical content in its aerosol reduced by 95% compared to traditional cigarettes. The development of the product has fully taken into account user feedback and is the result of continuous research and development investment.

 

PMI stated that smokeless products have had a positive impact on millions of adult users and their surrounding communities worldwide in recent years. According to data from the first quarter of 2025, smokeless products have accounted for over 40% of the company's total revenue. PMI plans to increase this percentage to two-thirds by the year 2030.

 

References:
[1] إطلاق جهاز IQOS ILUMA i الجديد في المملكة العربية السعودية
Also Read:
[1] PMI Vice President: Adoption of Smoke-Free Technologies in Africa Is Slow, Company to Step Up Promotion Efforts
[2] PMI Launches ZYN Nicotine Pouches in Guatemala, Marking First Entry in Central America

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

INTER-TABAC
INTER-TABAC
Global Tobacco Control Policy Debate: Medical Experts Call for Science-Based Approach, Promoting Harm Reduction Over Total Bans
Global Tobacco Control Policy Debate: Medical Experts Call for Science-Based Approach, Promoting Harm Reduction Over Total Bans
Health professionals worldwide are urging a shift from abstinence-only tobacco policies toward evidence-based harm reduction. Despite bans, smoking remains prevalent in countries like India, while prohibition fuels black markets in Europe and misinformation among doctors in the U.S. Many argue that regulated alternatives could save lives where cessation fails.
Sep.09
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Australia cracks down on major tobacco smuggling case, involving tax evasion exceeding US$24.21 million
Australia cracks down on major tobacco smuggling case, involving tax evasion exceeding US$24.21 million
Australian police seize tons of illicit tobacco and millions of cigarettes in Victoria's largest illegal tobacco case.
Sep.11 by 2FIRSTS.ai
InterTabac 2025 Insights | Caffeine and nicotine-free pouches hit the stage as white-label manufacturing and big players enter, heating up competition
InterTabac 2025 Insights | Caffeine and nicotine-free pouches hit the stage as white-label manufacturing and big players enter, heating up competition
2Firsts discovers at the 2025 InterTabac Exhibition in Dortmund, Germany that nicotine pouches are a top category.
Sep.24 by 2FIRSTS.ai
The New South Wales lower house of parliament in Australia passed a bill that could see up to seven years in prison for selling illegal tobacco
The New South Wales lower house of parliament in Australia passed a bill that could see up to seven years in prison for selling illegal tobacco
The NSW Lower House passed a bill cracking down on illegal tobacco. It allows health authorities to shut down non-compliant shops for up to 90 days and sets penalties of up to 7 years in prison or A$1.5 million in fines for large-scale sales. The opposition-led bill, backed by the government, targets organized crime funding and enhances public safety.
Sep.12 by 2FIRSTS.ai
The U.S. Department of Health and Human Services released a youth e-cigarette resource guide to address the proliferation of illegal products
The U.S. Department of Health and Human Services released a youth e-cigarette resource guide to address the proliferation of illegal products
U.S. HHS Surgeon General’s Office released a "Youth E-Cigarette Resource Guide" to tackle youth e-cig use. Though use fell, e-cigarettes are still middle/high schoolers’ top tobacco product—over 1.6M youth used them in 2024. Federal authorities seized millions of illegal devices, but sales persist, harming youth health. HHS and U.S. Customs recently seized $86.5M illegal e-cig products in a Chicago joint op.
Sep.16 by 2FIRSTS.ai
Related Topics
News Company
Related Read
Global Tobacco Control Policy Debate: Medical Experts Call for Science-Based Approach, Promoting Harm Reduction Over Total Bans
Global Tobacco Control Policy Debate: Medical Experts Call for Science-Based Approach, Promoting Harm Reduction Over Total Bans
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
2FIRSTS.ai
Australia cracks down on major tobacco smuggling case, involving tax evasion exceeding US$24.21 million
Australia cracks down on major tobacco smuggling case, involving tax evasion exceeding US$24.21 million
2FIRSTS.ai
InterTabac 2025 Insights | Caffeine and nicotine-free pouches hit the stage as white-label manufacturing and big players enter, heating up competition
InterTabac 2025 Insights | Caffeine and nicotine-free pouches hit the stage as white-label manufacturing and big players enter, heating up competition
2FIRSTS.ai
The New South Wales lower house of parliament in Australia passed a bill that could see up to seven years in prison for selling illegal tobacco
The New South Wales lower house of parliament in Australia passed a bill that could see up to seven years in prison for selling illegal tobacco
2FIRSTS.ai
The U.S. Department of Health and Human Services released a youth e-cigarette resource guide to address the proliferation of illegal products
The U.S. Department of Health and Human Services released a youth e-cigarette resource guide to address the proliferation of illegal products
2FIRSTS.ai
FOLLOW US ON SOCIAL MEDIA
Contact: info@2firsts.com
Stay up to date.
Submit your email to receive weekly newsletter on the most relevant news of the e-cigarette industry.
© 2025 Shenzhen 2FIRSTS Technology Co.,Ltd. All Right Reserved.
2FIRSTS is only accessible to industry practitioners, researchers, media and other professionals. Access by minors is prohibited.
This website provides services to users outside the Chinese mainland. For Chinese mainland users, please visit https://cn.2firsts.com
English
English
中文